OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Showing 8 citing articles:
Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers
Fatma G. Abdulrahman, Hamada S. Abulkhair, Hoda S. El Saeed, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107105-107105
Closed Access | Times Cited: 6
Fatma G. Abdulrahman, Hamada S. Abulkhair, Hoda S. El Saeed, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107105-107105
Closed Access | Times Cited: 6
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study
Wafaa A. Ewes, Samar S. Tawfik, Aya M. Almatary, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3186-3186
Open Access | Times Cited: 6
Wafaa A. Ewes, Samar S. Tawfik, Aya M. Almatary, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3186-3186
Open Access | Times Cited: 6
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
“Triazole-linked thiazolidinedione-Benzothiazole hybrids: Design and biological evaluation as AChE inhibitors”
Aya M. Almatary, Mohammad M. Al‐Sanea, Eman E. Nasr, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108295-108295
Closed Access
Aya M. Almatary, Mohammad M. Al‐Sanea, Eman E. Nasr, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108295-108295
Closed Access
Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4(3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Abdelrahman Hamdi, Samar S. Tawfik, Ahmed R. Ali, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107951-107951
Closed Access | Times Cited: 2
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access | Times Cited: 1
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access | Times Cited: 1
Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Unveiling the potential anticancer activity of new dihydropyrimidines through dual inhibition of EGFR and TrkA: Design, synthesis, and in silico study
Aya M Slly, Wafaa A. Ewes, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107962-107962
Closed Access
Aya M Slly, Wafaa A. Ewes, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107962-107962
Closed Access
